vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and CENTURY CASINOS INC (CNTY). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($191.2M vs $138.0M, roughly 1.4× CENTURY CASINOS INC). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (57.4% vs 0.2%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (48.1% CAGR vs 0.7%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Century Casinos, Inc. is a gambling company based in Colorado Springs, Colorado.
AXSM vs CNTY — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $191.2M | $138.0M |
| Net Profit | — | $-17.9M |
| Gross Margin | — | — |
| Operating Margin | -33.1% | 7.6% |
| Net Margin | — | -13.0% |
| Revenue YoY | 57.4% | 0.2% |
| Net Profit YoY | — | 80.1% |
| EPS (diluted) | — | $-0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | $138.0M | ||
| Q3 25 | $171.0M | $153.7M | ||
| Q2 25 | $150.0M | $150.8M | ||
| Q1 25 | $121.5M | $130.4M | ||
| Q4 24 | $118.8M | $137.8M | ||
| Q3 24 | $104.8M | $155.7M | ||
| Q2 24 | $87.2M | $146.4M |
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | $-17.9M | ||
| Q3 25 | $-47.2M | $-10.5M | ||
| Q2 25 | $-48.0M | $-12.3M | ||
| Q1 25 | $-59.4M | $-20.6M | ||
| Q4 24 | $-74.9M | $-90.3M | ||
| Q3 24 | $-64.6M | $-8.1M | ||
| Q2 24 | $-79.3M | $-41.6M |
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | 7.6% | ||
| Q3 25 | -27.0% | 11.1% | ||
| Q2 25 | -24.5% | 11.0% | ||
| Q1 25 | -46.9% | 5.5% | ||
| Q4 24 | -61.1% | -45.5% | ||
| Q3 24 | -59.8% | 11.5% | ||
| Q2 24 | -89.5% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | -13.0% | ||
| Q3 25 | -27.6% | -6.9% | ||
| Q2 25 | -32.0% | -8.2% | ||
| Q1 25 | -48.9% | -15.8% | ||
| Q4 24 | -63.1% | -65.6% | ||
| Q3 24 | -61.7% | -5.2% | ||
| Q2 24 | -91.0% | -28.4% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | $-0.62 | ||
| Q3 25 | $-0.94 | $-0.35 | ||
| Q2 25 | $-0.97 | $-0.40 | ||
| Q1 25 | $-1.22 | $-0.67 | ||
| Q4 24 | $-1.54 | $-2.95 | ||
| Q3 24 | $-1.34 | $-0.26 | ||
| Q2 24 | $-1.67 | $-1.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $305.1M | $68.9M |
| Total DebtLower is stronger | $70.0M | $328.9M |
| Stockholders' EquityBook value | — | $-97.7M |
| Total Assets | $713.6M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | $68.9M | ||
| Q3 25 | $325.3M | $77.7M | ||
| Q2 25 | $303.0M | $85.5M | ||
| Q1 25 | $300.9M | $84.7M | ||
| Q4 24 | $315.4M | $98.8M | ||
| Q3 24 | $327.3M | $118.8M | ||
| Q2 24 | $315.7M | $123.2M |
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | $328.9M | ||
| Q3 25 | — | $329.3M | ||
| Q2 25 | — | $328.0M | ||
| Q1 25 | — | $328.8M | ||
| Q4 24 | — | $328.2M | ||
| Q3 24 | — | $327.5M | ||
| Q2 24 | — | $328.8M |
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | $-97.7M | ||
| Q3 25 | $73.7M | $-78.6M | ||
| Q2 25 | $73.1M | $-66.9M | ||
| Q1 25 | $53.2M | $-54.3M | ||
| Q4 24 | $57.0M | $-34.7M | ||
| Q3 24 | $92.9M | $56.8M | ||
| Q2 24 | $102.9M | $64.6M |
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | $1.1B | ||
| Q3 25 | $669.3M | $1.2B | ||
| Q2 25 | $639.8M | $1.2B | ||
| Q1 25 | $596.7M | $1.2B | ||
| Q4 24 | $568.5M | $1.2B | ||
| Q3 24 | $561.5M | $1.3B | ||
| Q2 24 | $548.2M | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.77× | ||
| Q2 24 | — | 5.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-114.0K |
| Free Cash FlowOCF − Capex | — | $-4.7M |
| FCF MarginFCF / Revenue | — | -3.4% |
| Capex IntensityCapex / Revenue | — | 3.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-15.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $-114.0K | ||
| Q3 25 | $1.0M | $144.0K | ||
| Q2 25 | $-32.4M | $11.3M | ||
| Q1 25 | $-43.4M | $-4.6M | ||
| Q4 24 | $-26.2M | $-2.3M | ||
| Q3 24 | $-18.6M | $7.4M | ||
| Q2 24 | $-30.1M | $3.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $-4.7M | ||
| Q3 25 | $988.0K | $-4.7M | ||
| Q2 25 | $-32.4M | $5.5M | ||
| Q1 25 | $-43.7M | $-11.3M | ||
| Q4 24 | $-26.2M | $-16.9M | ||
| Q3 24 | $-18.7M | $-2.8M | ||
| Q2 24 | $-30.2M | $-12.9M |
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | -3.4% | ||
| Q3 25 | 0.6% | -3.1% | ||
| Q2 25 | -21.6% | 3.6% | ||
| Q1 25 | -36.0% | -8.7% | ||
| Q4 24 | -22.1% | -12.3% | ||
| Q3 24 | -17.9% | -1.8% | ||
| Q2 24 | -34.6% | -8.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.3% | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.0% | 3.9% | ||
| Q1 25 | 0.3% | 5.1% | ||
| Q4 24 | 0.0% | 10.7% | ||
| Q3 24 | 0.1% | 6.6% | ||
| Q2 24 | 0.1% | 10.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
CNTY
| Gaming | $103.9M | 75% |
| Food And Beverage | $13.2M | 10% |
| Hotel | $10.5M | 8% |
| Other | $5.2M | 4% |
| Pari Mutuel And Sports Betting And Igaming | $5.2M | 4% |
